Going for Gold with Myopia Control - Meet Violet, an accomplished young figure skater with aspirations of Olympic gold...
MiSight® 1 day for daily wear | Patient Stories
Violet Ice Skating
Violet’s Story
Going for Gold with Myopia Control
Meet Violet, an accomplished young figure skater with aspirations of Olympic gold. By the time she turned nine, her family began to observe signs of myopia and worried how that would impact Violet in doing what she loves. When Violet’s eye care professional prescribed MiSight® 1 day myopia control contact lenses for age appropriate children,* it was a win-win for her lifestyle and her future eye health.†1 Since she began wearing the lenses, her myopia has not gotten worse.‡±2
Violet's MiSight® Story Video
Discover Violet’s MiSight® Story
“We can’t control Violet having myopia because, as we know, myopia is caused by genetic and environmental factors.3 But, one thing that we can do right now is to take control and to be proactive in slowing down the progression of her myopia. That’s why we chose MiSight® 1 day contact lenses for Violet.”
Kofen, Violet’s Dad
Join CooperVision in Taking on Myopia.
Share our YouTube channel with patients and parents for more videos to further myopia awareness and education.
CooperVision | MiSight® 1 day for daily wear
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
†77% strongly agree, 20% somewhat agree.
‡Children aged 8-12 at the initiation of treatment.
± No clinically meaningful change in refractive error -0.25D or less from baseline.
1. CVI data on file 2022. U.S. CooperVision online survey: ECP MiSight® 1 day Perspectives; n=101 ECPs that prescribe MiSight® 1 day.
2. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
3. Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik K. Parental myopia, near work, school achievement, and children's refractive error. Invest Ophthalmol Vis Sci. 2002;43(12):3633-3640. doi:10.1001/jamaophthalmol.2020.0412


Review of Optometry® is published by the Review Group, a Division of Jobson Medical Information LLC (JMI), 19 Campus Boulevard, Newtown Square, PA 19073.

To subscribe to other JMI newsletters or to manage your subscription, click here.

To change your email address, reply to this email. Write "change of address" in the subject line. Make sure to provide us with your old and new address.

To ensure delivery, please be sure to add revoptom@lists.jobsonmail.com to your address book or safe senders list.

Click here if you do not want to receive future emails from Review of Optometry.